Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 145.03%834.19M | 145.03%834.19M | --422.73M | 3.35%430.71M | --481.15M | -27.21%340.45M | -27.21%340.45M | 345.89%416.76M | 678.10%467.73M | 678.10%467.73M |
-Cash and cash equivalents | 126.68%771.74M | 126.68%771.74M | --422.73M | 3.35%430.71M | --481.15M | -27.21%340.45M | -27.21%340.45M | 345.89%416.76M | 678.10%467.73M | 678.10%467.73M |
-Short-term investments | --62.45M | --62.45M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Receivables | 1,032.64%21.31M | 1,032.64%21.31M | --5.15M | -13.77%5.41M | --4.13M | -9.13%1.88M | -9.13%1.88M | -94.81%6.27M | -57.38%2.07M | -57.38%2.07M |
-Taxes receivable | -68.09%321K | -68.09%321K | --3.5M | --3.27M | --148K | -51.40%1.01M | -51.40%1.01M | ---- | -57.38%2.07M | -57.38%2.07M |
-Other receivables | 2,298.17%20.98M | 2,298.17%20.98M | --1.65M | -65.96%2.13M | --3.99M | --875K | --875K | --6.27M | ---- | ---- |
Prepaid assets | 77.53%7.92M | 77.53%7.92M | --10M | --9.24M | --2.54M | -45.48%4.46M | -45.48%4.46M | ---- | 384.29%8.18M | 384.29%8.18M |
Total current assets | 148.97%863.41M | 148.97%863.41M | --437.87M | 5.28%445.35M | --487.82M | -27.45%346.79M | -27.45%346.79M | 86.66%423.03M | 617.06%477.98M | 617.06%477.98M |
Non current assets | ||||||||||
Net PPE | 566.34%673K | 566.34%673K | --724K | 547.41%788K | --139K | -34.42%101K | -34.42%101K | -33.42%121.72K | -28.41%154K | -28.41%154K |
-Gross PPE | 566.34%673K | 566.34%673K | --724K | --788K | --139K | -34.42%101K | -34.42%101K | ---- | -33.65%154K | -33.65%154K |
Goodwill and other intangible assets | 214.12%534K | 214.12%534K | --593K | -99.39%542K | --486K | -18.27%170K | -18.27%170K | --88.71M | --208K | --208K |
Non current prepaid assets | --0 | --0 | --0 | -92.08%8K | --16K | -77.56%35K | -77.56%35K | --101.07K | --156K | --156K |
Total non current assets | 294.44%1.21M | 294.44%1.21M | --1.32M | -98.50%1.34M | --641K | -40.93%306K | -40.93%306K | 9,328.14%88.93M | -49.61%518K | -49.61%518K |
Total assets | 149.10%864.62M | 149.10%864.62M | --439.19M | -12.75%446.69M | --488.46M | -27.46%347.1M | -27.46%347.1M | 124.97%511.96M | 606.93%478.5M | 606.93%478.5M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -71.97%4.74M | -71.97%4.74M | --7.04M | -76.72%5.28M | --8.54M | 42.77%16.92M | 42.77%16.92M | 84.14%22.66M | 16.41%11.85M | 16.41%11.85M |
-accounts payable | -71.97%4.74M | -71.97%4.74M | --7.04M | -76.72%5.28M | --8.54M | 42.77%16.92M | 42.77%16.92M | 84.14%22.66M | 68.34%11.85M | 68.34%11.85M |
Current accrued expenses | -39.02%4.89M | -39.02%4.89M | --6.39M | --10.19M | --9.97M | 94.56%8.01M | 94.56%8.01M | ---- | 870.13%4.12M | 870.13%4.12M |
Current debt and capital lease obligation | 310.00%246K | 310.00%246K | --240K | 236.44%234K | --43K | -9.09%60K | -9.09%60K | 9.15%69.55K | 9.99%66K | 9.99%66K |
-Current capital lease obligation | 310.00%246K | 310.00%246K | --240K | 236.44%234K | --43K | -9.09%60K | -9.09%60K | 9.15%69.55K | 9.99%66K | 9.99%66K |
Current deferred liabilities | -32.81%6.01M | -32.81%6.01M | --4.5M | -42.46%6.06M | --8.12M | -35.55%8.94M | -35.55%8.94M | -28.30%10.53M | --13.87M | --13.87M |
Other current liabilities | 554.62%82.31M | 554.62%82.31M | --18.9M | 180.39%23.55M | --33.06M | 203.21%12.57M | 203.21%12.57M | --8.4M | 366,171.33%4.15M | 366,171.33%4.15M |
Current liabilities | 114.28%106.92M | 114.28%106.92M | --41.26M | 8.75%45.31M | --59.73M | 38.38%49.9M | 38.38%49.9M | 53.97%41.66M | 222.33%36.06M | 222.33%36.06M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | --202K | --202K | --266K | 1,212.26%328K | ---- | --0 | --0 | -73.41%25K | -52.26%60K | -52.26%60K |
-Long term capital lease obligation | --202K | --202K | --266K | 1,212.26%328K | ---- | --0 | --0 | -73.41%25K | -52.26%60K | -52.26%60K |
Non current deferred liabilities | --0 | --0 | --0 | -93.01%222K | --444K | -78.74%1.02M | -78.74%1.02M | -59.13%3.18M | --4.79M | --4.79M |
Derivative product liabilities | --0 | --0 | --18.81M | 63.18%13.39M | --16.49M | 3.54%7.79M | 3.54%7.79M | --8.21M | --7.52M | --7.52M |
Total non current liabilities | -97.71%202K | -97.71%202K | --19.07M | 22.21%13.94M | --16.93M | -28.83%8.81M | -28.83%8.81M | 45.06%11.41M | 9,745.91%12.37M | 9,745.91%12.37M |
Total liabilities | 82.47%107.12M | 82.47%107.12M | --60.33M | 11.65%59.25M | --76.66M | 21.21%58.7M | 21.21%58.7M | 51.96%53.07M | 328.14%48.43M | 328.14%48.43M |
Shareholders'equity | ||||||||||
Share capital | 32.15%13.44M | 32.15%13.44M | --11.44M | -98.31%11.15M | --11.11M | 1.17%10.17M | 1.17%10.17M | 287.22%661.56M | -89.41%10.06M | -89.41%10.06M |
-common stock | 32.15%13.44M | 32.15%13.44M | --11.44M | -98.31%11.15M | --11.11M | 1.17%10.17M | 1.17%10.17M | 287.22%661.56M | -89.41%10.06M | -89.41%10.06M |
Retained earnings | -76.22%-558.57M | -76.22%-558.57M | ---466.39M | -112.82%-449.75M | ---410.74M | -126.35%-316.97M | -126.35%-316.97M | -1,119.86%-211.33M | -256.68%-140.04M | -256.68%-140.04M |
Paid-in capital | 119.74%1.3B | 119.74%1.3B | --829.4M | --821.61M | --807.01M | 6.33%590.77M | 6.33%590.77M | ---- | --555.63M | --555.63M |
Gains losses not affecting retained earnings | 1.02%4.47M | 1.02%4.47M | --4.42M | -48.96%4.42M | --4.42M | 0.00%4.42M | 0.00%4.42M | 706.09%8.66M | 560.85%4.42M | 560.85%4.42M |
Total stockholders'equity | 162.66%757.5M | 162.66%757.5M | --378.86M | -15.57%387.44M | --411.8M | -32.94%288.39M | -32.94%288.39M | 138.21%458.89M | 662.87%430.07M | 662.87%430.07M |
Total equity | 162.66%757.5M | 162.66%757.5M | --378.86M | -15.57%387.44M | --411.8M | -32.94%288.39M | -32.94%288.39M | 138.21%458.89M | 662.87%430.07M | 662.87%430.07M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- |